The struggle against HIV may be undergoing a sea change.
By Helen Branswell, STAT
The PBS NewsHour Weekend reporting team is gathering stories about the high cost of prescription drugs and patients’ experiences at the pharmacy.
By Megan Thompson
The pathway to deadly heart infections for people addicted to opioids often begins with a dirty needle or polluted drug. Special correspondent Kay Colby of Ideastream reports on a little-known problem with big consequences for patients and society as a…
By Kay Colby, ideastream
Amid several lawsuits that accuse manufacturing giant Purdue Pharma of contributing to the country’s opioid epidemic, the company announced Saturday it will cut sales staff by more than half and stop marketing opioids to doctors. Reporter Lev Facher, who wrote…
By PBS NewsHour
By Matthew Perrone, Ricardo Alonso-Zaldivar, Associated Press
As a candidate, Trump advocated Medicare negotiations and he called for allowing consumers to import lower-priced medicines from abroad. But the White House strategy paper veers away from such dramatic steps.
2017 marked Acapulco's fifth straight year of being Mexico's most murderous city. Once an internationally renowned tropical paradise, violence has shot up over the last decade. But while police and military forces protect tourists, residents say little is done to…
It's not part of Cancun that tourists travel to see: heavily armed police working to stop a soaring homicide rate. The fallout of Mexico's campaign targeting drug cartel leaders is spilling onto the periphery of the famous beach destination, where…
By Fred de Sam Lazaro
Fake pharmaceuticals are a multi-billion dollar problem around the world. Made and packaged to look like the real deal, these phonies may contain a fraction of the active ingredients or none at all. these fake drugs can have serious consequences…
By Associated Press
The Committee on Energy and Commerce is expected to give an update on efforts to combat the opioid crisis at 10 a.m. ET.
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.